RASGRF2 and neoplasm: In particular, it is known that GRF2 suppresses CDC42-mediated cell movements and cytoskeletal dynamics in tumor cells [28] In this regard, it has been shown that GRF2 can bind to 14-3-3 proteins, while 14-3-3 proteins can bind and increase CDC42 activity [50].